Brief: Guerbet Announces Marketing Authorisation Approval Of Elucirem™ (Gadopiclenol) In The European Union
Guerbet SA GRBT.PA :
* GUERBET ANNOUNCES MARKETING AUTHORISATION APPROVAL OF
ELUCIREM™
(GADOPICLENOL) IN THE EUROPEAN UNION
Source text for Eikon: ID:nPrez1Dpja
Further company coverage: GRBT.PA
Recent news on Guerbet SA
See all newsBrief: Guerbet Q1 Revenue At EUR 177.4 Mln
Guerbet Q1 revenue up 2.6% at CER on increased volumes in EMEA and Asia
Medical imaging firm Guerbet's 2025 revenue falls on lower sales activity in France
Brief: Guerbet Says FDA Approves Labeling Update For Guerbet's Elucirem Injection
France's Guerbet misses 2025 revenue estimates